GMKBData and Safety Monitoring Board (DSMB)
The DSMB is responsible for safeguarding the interests of trial participants by assessing the safety and efficacy of the interventions during the trial, and for monitoring the overall conduct and progress of the trial to ensure that the results will be interpretable and of value to medical practice. The DSMB provides recommendations to the Division of Genomic Medicine (DGM), National Human Genome Research Institute (NHGRI), NIH about stopping, continuing, or making modifications to the trial to enhance the safety of trial participants, the value of the information collected, and/or to protect the integrity of the trial.
Members
DSMB Chair:
Bruce Korf, M.D., Ph.D.
University of Alabama
DSMB Members:
Timothy Thornton, Ph.D.
University of Washington
James Neaton, Ph.D.
University of Minnesota
Stephen Wisniewski, Ph.D.
Pittsburgh University
Mary Relling, PharmD
St. Jude
Karen Johnson, M.D., MPH
University of Tennessee Health Science Center
Peter O'Donnell, M.D.
University of Chicago
Jordan Smoller, M.D., Sc.D.
Massachusetts General Hospital
Executive Secretary:
Simona Volpi, PharmD, Ph.D.
Program Director
Division of Genomic Medicine
NHGRI
NHGRI ex officio members:
Teri Manolio, M.D., Ph.D.
Director
Division of Genomic Medicine
NHGRI
Ebony Madden, Ph.D.
Program Director
Division of Genomic Medicine
NHGRI
Sylvia Garvey, MPH, CPH
Scientific Program Specialist
Division of Genomic Medicine
NHGRI
Nicole Lockhart, Ph.D.
Program Director
Division of Genomes and Society
NHGRI
Michelle Cohen
Scientific Program Analyst
Division of Genomic Medicine
NHGRI